CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.855
EU - Europa 7.696
AS - Asia 2.098
SA - Sud America 108
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 9
OC - Oceania 3
Totale 19.818
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.809
IT - Italia 2.434
SE - Svezia 1.601
IE - Irlanda 1.248
TR - Turchia 681
DE - Germania 657
CN - Cina 617
UA - Ucraina 601
SG - Singapore 596
GB - Regno Unito 358
FI - Finlandia 230
RU - Federazione Russa 152
CH - Svizzera 128
BR - Brasile 99
AT - Austria 87
IL - Israele 59
BE - Belgio 54
EU - Europa 47
CA - Canada 44
VN - Vietnam 39
FR - Francia 35
AL - Albania 22
NL - Olanda 21
ID - Indonesia 20
JP - Giappone 19
KR - Corea 11
IN - India 9
DK - Danimarca 7
ES - Italia 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
IQ - Iraq 6
PK - Pakistan 6
PL - Polonia 6
RS - Serbia 6
HK - Hong Kong 5
LT - Lituania 5
BG - Bulgaria 4
EG - Egitto 4
LU - Lussemburgo 4
AR - Argentina 3
CL - Cile 3
IR - Iran 3
PT - Portogallo 3
TH - Thailandia 3
TW - Taiwan 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BD - Bangladesh 2
BN - Brunei Darussalam 2
GR - Grecia 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
MD - Moldavia 2
MT - Malta 2
PH - Filippine 2
RO - Romania 2
AM - Armenia 1
AZ - Azerbaigian 1
EC - Ecuador 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
VE - Venezuela 1
Totale 19.818
Salva come PNG Salva come JPEG
Città #
Pisa 1.688
Chandler 1.373
Jacksonville 1.300
Dublin 1.246
Boardman 854
Izmir 529
Wilmington 526
Ashburn 510
Singapore 426
Ann Arbor 399
Boston 283
Millbury 264
Düsseldorf 220
Mestre 188
San Mateo 181
New York 157
Istanbul 148
Ogden 121
Bremen 119
Seattle 109
Bern 107
Princeton 106
Washington 93
Lawrence 91
Woodbridge 88
Beijing 81
Vienna 79
San Paolo di Civitate 67
Saint Petersburg 63
Milan 58
Helsinki 56
Guangzhou 54
Dearborn 53
Holon 51
Brussels 50
Munich 50
Shanghai 48
Dong Ket 39
Scuola 38
Los Angeles 36
Wuhan 33
Santa Clara 32
Toronto 30
Rome 29
San Giuliano Terme 28
Fairfield 26
Hefei 24
Norwalk 23
Chicago 21
Nanjing 21
Jakarta 20
Houston 19
Las Vegas 19
Bientina 16
Florence 16
Jiaxing 16
Edinburgh 15
Tokyo 15
Andover 14
Kunming 14
Berlin 13
Shenzhen 13
Frankfurt am Main 12
Padova 12
Wuxi 12
London 11
San Diego 11
Cambridge 10
Lausanne 10
Falls Church 9
Ferrara 9
Jinan 9
Paris 9
Zurich 9
Amsterdam 8
Livorno 8
Stockholm 8
Tappahannock 8
Voghera 8
Auburn Hills 7
Seoul 7
Verona 7
Yiwu 7
Budapest 6
Cusano Milanino 6
Graz 6
Nanchang 6
Shenyang 6
São Paulo 6
Trieste 6
Centrale 5
Hangzhou 5
Ottawa 5
Prague 5
Quanzhou 5
Redmond 5
Shaoxing 5
Tiantai Chengguanzhen 5
Albano Laziale 4
Cascina 4
Totale 12.687
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.062
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 171
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 168
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 167
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 166
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 160
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 158
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 156
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 152
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 151
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 145
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 144
NGF steers microglia toward a neuroprotective phenotype 139
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 136
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 132
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 130
null 129
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 128
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 127
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 127
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 126
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 125
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 123
Nerve Growth Factor regulates astrocyte physiology in vivo 119
The role of Nerve Growth Factor in development and in ALzheimer's disease 118
Morphological basis for pineal secretion in domestic Ungulata 117
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 117
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 117
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 116
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 116
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 116
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 114
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 114
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 113
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 113
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 113
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 113
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 112
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 112
Involvement of NGF in early stages of chick embryo development 112
A new generation of NGF-based therapy for Alzheimer’s disease 112
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 111
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 109
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 109
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 109
Intranasal delivery of therapeutic proteins for neurological diseases 109
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 108
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 108
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 108
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 108
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 108
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 107
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 106
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 106
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 106
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 104
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 104
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 103
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 103
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 103
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 103
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 102
The effects of knocking out of p75NTR on the neurodegenerative phenotype in AD11 anti-NGF mice 101
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 101
Expression of the melatonin receptors in Xenopus laevis 101
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 101
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 101
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 100
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 100
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 100
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 99
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 99
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 98
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 97
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 97
Development of human Nerve Growth Factor muteins with reduced algesic properties 97
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 97
Transgenic mouse models of neurotrophin function and effects on amyloid plaques and neurofibrillary pathology 97
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 97
Interfering with the intracellular trafficking of Aß Oligomers with conformational intrabodies 96
Memoquin, a novel multifunctional compound for Alzheimer’s disease: an up-date on preclinical studies 95
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 95
Memoquin, a new compound to attack Alzheimer's disease: preclinical studies 95
Rage deficiency rescues Aß-mediated inhibitory effects of different forms of long-term potentiation in mouse neocortex 94
Phenotypic characterization of mice expressing anti-TrkA antibodies 94
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 94
Design and characterization of human Nerve Growth Factor muteins with reduced algesic properties and their application to drug discovery in Alzheimer’s disease 93
Rat visual cortical neurones express TrkA NGF receptor 93
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 93
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 93
A small molecule targeting the multifactorial nature of Alzheimer's disease 93
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 92
Development of a non-invasive NGF-based therapy for Alzheimer's disease. Current Alzheimer Research 6: 158 92
Organotypic cultures from AD11 anti-NGF transgenic mice: an in vitro model system to study neurodegeneration 92
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 92
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 92
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 92
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 91
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 91
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 91
Totale 13.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020783 0 0 0 0 0 0 300 53 191 32 195 12
2020/20212.437 195 17 501 16 185 216 76 197 209 421 128 276
2021/20221.470 141 14 11 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.921 268 47 215 47 137 388 72 106 209 72 10 350
2024/20254.053 1.665 292 269 738 904 180 5 0 0 0 0 0
Totale 20.097